Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00398645 · ClinicalTrials.gov registry record · Phase 2
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma.
A Phase 2 study of Asthma, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 2
- Development phase
- 648
- Enrollment target
- 20
- Study locations
NCT00398645 is a Phase 2 study of Asthma that has completed, run by GlaxoSmithKline. The registered enrollment target is 648 participants, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (59% lower). The trial reports 20 study locations across 11 states.
The verdict
NCT00398645, a Phase 2 study of Asthma, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 648 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study is designed to determine if the investigational drug is effective and safe in individuals with asthma.
Conditions Studied
Interventions
- DRUG GW685698X 200mcg,GW685698X 200mcg and 400mcg
Study Locations (20)
California
- GSK Investigational Site - Fullerton
- GSK Investigational Site - Huntington Beach
- GSK Investigational Site - Orange
- GSK Investigational Site - San Diego
Oregon
- GSK Investigational Site - Lake Oswego
- GSK Investigational Site - Medford
- GSK Investigational Site - Portland
Ohio
- GSK Investigational Site - Dayton
- GSK Investigational Site - Sylvania
Texas
- GSK Investigational Site - El Paso
- GSK Investigational Site - San Antonio
New South Wales
- GSK Investigational Site - Camperdown
- GSK Investigational Site - Concord
South Australia
- GSK Investigational Site - Adelaide
- GSK Investigational Site - Toorak Gardens
Florida
- GSK Investigational Site - Miami
Massachusetts
- GSK Investigational Site - North Dartmouth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 648 participants |
| Start Date | 2006-11-15 |
| Est. Completion | 2007-08-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00398645
The ClinicalTrials.gov registry entry for NCT00398645 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 648 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (59% lower). The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which GW685698X 200mcg,GW685698X 200mcg and 400mcg is the first listed.
NCT00398645 reports 20 study locations spanning 11 distinct geographic areas - top geographies include California, Oregon, Ohio.
Frequently Asked Questions
What is clinical trial NCT00398645 about?
NCT00398645 is a clinical study titled "A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma.". This study is designed to determine if the investigational drug is effective and safe in individuals with asthma.
What is the current status of trial NCT00398645?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 648 participants. The study started on 2006-11-15. Estimated completion is 2007-08-30.
What conditions does trial NCT00398645 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT00398645?
The interventions under investigation include: GW685698X 200mcg,GW685698X 200mcg and 400mcg (DRUG).
Who is sponsoring clinical trial NCT00398645?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00398645 being conducted?
This trial has 20 study locations across California, Florida, Massachusetts, Missouri, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
RECRUITING · Phase 2
-
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
RECRUITING · Phase 2
-
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
RECRUITING · Phase 2
-
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 2
-
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.